MONROVIA, Md. (AP) — MONROVIA, Md. (AP) — Crescent Biopharma, Inc. (CBIO) on Thursday reported a loss of $21.8 million in its second quarter.
The Monrovia, Maryland-based company said it had a loss of $4.93 per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $2.69 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CBIO at https://www.zacks.com/ap/CBIO
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
